Oscar Moreno Loaiza (@oscarmoreno511) 's Twitter Profile
Oscar Moreno Loaiza

@oscarmoreno511

MD, MSc, PhD.
Cross-talk between immune cells and cardiac electrophisiology
@IBCCF_UFRJ, #electrophysiolophy, #cardioimmunology, #atrialfibrillation.

ID: 1563363341870850048

calendar_today27-08-2022 03:11:38

316 Tweet

38 Followers

132 Following

Nature Cardiovascular Research (@naturecvr) 's Twitter Profile Photo

❤️Our March issue is out❤️Featuring the cardiovascular polypill’s path to the WHO’s Essential Medicines list, tricaprin’s applications in cardiomyovasculopathy, NAD+ deficiency in aortic aneurysm, HF targets identified via multi-omics approaches, and more! nature.com/natcardiovascr…

❤️Our March issue is out❤️Featuring the cardiovascular polypill’s path to the WHO’s Essential Medicines list, tricaprin’s applications in cardiomyovasculopathy, NAD+ deficiency in aortic aneurysm, HF targets identified via multi-omics approaches, and more!
nature.com/natcardiovascr…
Oscar Moreno Loaiza (@oscarmoreno511) 's Twitter Profile Photo

Muito obrigado pela nota CNPq. O papel da agencia foi fundamental e me deu minha primeira bolsa de doutorado para realizar este estudo que foi minha tese doutoral. #maisbolsas #apoioapesquisa

Ivan Zanoni (@lo_zanzi) 's Twitter Profile Photo

#MustRead. For #TumorImminologyLovers & more, check this fantastic review Renato Ostuni nicoletta caronni &co Trends in Immunology all about #IL1 from #macrophages & pathogenic #inflammation in #cancer. #ScienceMatters dlvr.it/TJslPb

ESC Council on Stroke Chairperson (@escstrokechair) 's Twitter Profile Photo

Just released!📣 #ESCStroke & #ESC_EHRA Consensus Statement on atrial fibrillation burden in clinical practice, research, and technology development 🖇️tinyurl.com/yckhhfs5 Wolfram Doehner Europace Editor-in-Chief EHRAPresident Jose Luis Merino Boriani Giuseppe #Afib #stroke

Just released!📣
#ESCStroke & #ESC_EHRA Consensus Statement on atrial fibrillation burden in clinical practice, research, and technology development

🖇️tinyurl.com/yckhhfs5

<a href="/WoDoehner/">Wolfram Doehner</a> <a href="/EuropaceEiC/">Europace Editor-in-Chief</a> <a href="/EHRAPresident/">EHRAPresident</a> <a href="/joselmerino/">Jose Luis Merino</a> <a href="/BorianiGiuseppe/">Boriani Giuseppe</a> 

#Afib #stroke
ESC Council on Stroke Chairperson (@escstrokechair) 's Twitter Profile Photo

Survivors of ischemic #stroke face a high risk of early heart complications (within 4 weeks): 👉11.1% develop #ACS 👉8.8% #Afib 🚨Early monitoring is critical! Read more🖇️ tinyurl.com/429kd6w6 #StrokeHeartSyndrome #ESCstroke Jacopo Imberti Liverpool Centre for Cardiovascular Science

Survivors of ischemic #stroke face a high risk of early heart complications (within 4 weeks): 

👉11.1% develop #ACS 
👉8.8% #Afib 
🚨Early monitoring is critical! 

Read more🖇️
tinyurl.com/429kd6w6

#StrokeHeartSyndrome #ESCstroke <a href="/JacopoImberti/">Jacopo Imberti</a> <a href="/LiverpoolCCS/">Liverpool Centre for Cardiovascular Science</a>
Eric Topol (@erictopol) 's Twitter Profile Photo

Just published NEJM A randomized trial of Semaglutide (Ozempic) vs Tirzepatide (Mounjaro, Zepbound) at max doses demonstrates superiority of the latter for weight loss nejm.org/doi/full/10.10…

Just published <a href="/NEJM/">NEJM</a> 
A randomized trial of Semaglutide (Ozempic) vs Tirzepatide (Mounjaro, Zepbound) at max doses demonstrates superiority of the latter for weight loss
nejm.org/doi/full/10.10…
ESC Council on Stroke Chairperson (@escstrokechair) 's Twitter Profile Photo

📡 Long-term ICM monitoring after cryptogenic #stroke reveals hidden risks: tinyurl.com/35mk5vw6 🧠1/3 pts developed subclinical AF ⏱️Median detection at ~7 mnts 💊96% started OACs Jacopo Imberti European Society of Cardiology Francesco Vitali Luca Bergamaschi

📡 Long-term ICM monitoring after cryptogenic #stroke reveals hidden risks: tinyurl.com/35mk5vw6
🧠1/3 pts developed subclinical AF 
⏱️Median detection at ~7 mnts 
💊96% started OACs

<a href="/JacopoImberti/">Jacopo Imberti</a> <a href="/escardio/">European Society of Cardiology</a> <a href="/Fra_Vitali90/">Francesco Vitali</a> <a href="/L_Bergamaschi/">Luca Bergamaschi</a>
Eric Topol (@erictopol) 's Twitter Profile Photo

Metformin, the first line drug for Type 2 diabetes, has been used for 60 years without a clearcut mechanism of action. It turns out it's not just reducing glucose output from the liver. Metformin also works via the brain science.org/doi/10.1126/sc…

Oscar Moreno Loaiza (@oscarmoreno511) 's Twitter Profile Photo

Happy to see our last paper at a #ESC2025 session. Emiliano Medei next to the best researchers in cardiac macrophages. #cardioimunology #macrophages #atrialfibrillation

Happy to see our last paper at a #ESC2025 session. <a href="/emedei70/">Emiliano Medei</a>  next to the best researchers in cardiac macrophages. #cardioimunology #macrophages #atrialfibrillation
Ivan Zanoni (@lo_zanzi) 's Twitter Profile Photo

#InterferonPower! Thrilled for our latest work Cell! With Daniel Böhmer, we dug into tons of papers & created what we hope will be a go-to resource for immunologists & non-immunologist about type I, II, III (& IV😉) #interferons! Free link 👉 authors.elsevier.com/a/1leKGL7PXuFTj

#InterferonPower! Thrilled for our latest work <a href="/CellCellPress/">Cell</a>! With <a href="/dfrboehmer/">Daniel Böhmer</a>, we dug into tons of papers &amp; created what we hope will be a go-to resource for immunologists &amp; non-immunologist about type I, II, III (&amp; IV😉) #interferons! Free link 👉 authors.elsevier.com/a/1leKGL7PXuFTj
Concepcion Campos-Asensio (@bibliogetafe) 's Twitter Profile Photo

📚Nueva guía (Medicine 2025) sobre cómo realizar #RevisionesSistemáticas y #metaanálisis: desde formular la pregunta con frameworks como PICO/SPIDER, buscar en PubMed/Embase, evaluar calidad (RoB2, AMSTAR 2…), análisis en R o RevMan y manejo de sesgos. 🔗pmc.ncbi.nlm.nih.gov/articles/PMC12…

📚Nueva guía (Medicine 2025) sobre cómo realizar #RevisionesSistemáticas y #metaanálisis: desde formular la pregunta con frameworks como PICO/SPIDER, buscar en PubMed/Embase, evaluar calidad (RoB2, AMSTAR 2…), análisis en R o RevMan y manejo de sesgos. 
🔗pmc.ncbi.nlm.nih.gov/articles/PMC12…
Jose Luis Merino (@joselmerino) 's Twitter Profile Photo

The EHRA Antiarrhythmic Drug Compendium is now published in full A practical, comprehensive resource for the safe and effective use of AADs in daily practice.

The EHRA Antiarrhythmic Drug Compendium is now published in full 
A practical, comprehensive resource for the safe and effective use of AADs in daily practice.
Niels Voigt (@niels_voigt) 's Twitter Profile Photo

Fresh off the press! 🚨 Our latest study on blebbistatin’s effects on EC coupling is now online in Journal of Physiology. Huge congratulations to Izzat Sobitov and Katharina Ritzenhoff for their outstanding work! 🔗 doi.org/10.1113/JP2875… Institute of Pharmacology and Toxicology, UMG Aiste Liutkute Faks Will Seibertz

Fresh off the press! 🚨 Our latest study on blebbistatin’s effects on EC coupling is now online in <a href="/JPhysiol/">Journal of Physiology</a>. Huge congratulations to <a href="/izzy_sob/">Izzat Sobitov</a> and Katharina Ritzenhoff for their outstanding work!

🔗 doi.org/10.1113/JP2875…

<a href="/pharmaumg/">Institute of Pharmacology and Toxicology, UMG</a> <a href="/aiste_liutkute/">Aiste Liutkute</a> <a href="/funshofaks/">Faks</a> <a href="/WillSeibertz/">Will Seibertz</a>
Oscar Moreno Loaiza (@oscarmoreno511) 's Twitter Profile Photo

🚨 Emiliano Medei presenting our latest paper at #ESCcongress #ESC2025! How IL-1β drives atrial fibrillation by priming cardiac resident macrophages and not cardiomyocytes. #Cardiology #cardioimmunology

🚨 <a href="/emedei70/">Emiliano Medei</a> presenting our latest paper at #ESCcongress #ESC2025!
How IL-1β drives atrial fibrillation by priming cardiac resident macrophages and not cardiomyocytes. 
#Cardiology #cardioimmunology
CVR Tomasz Guzik (@cvr_tomaszguzik) 's Twitter Profile Photo

Peter Libby explores the future of #inflammation & #immunity in #cardiovascular disease as well as what we can learn from past trials as we conclude this fantastic #CardiovascularResearch Special Session at #ESCCongress

Peter Libby explores the future of #inflammation &amp; #immunity in #cardiovascular disease as well as what we can learn from past trials as we conclude this fantastic #CardiovascularResearch Special Session at #ESCCongress
European Society of Cardiology Journals (@esc_journals) 's Twitter Profile Photo

Simultaneous publication during #ESCCongress Hypokalemia as a trigger for atrial fibrillation: Insights from patients with implanted loop recorders - ow.ly/5wPK50WOx1g #EHJ

Simultaneous publication during #ESCCongress 

Hypokalemia as a trigger for atrial fibrillation: Insights from patients with implanted loop recorders - ow.ly/5wPK50WOx1g

#EHJ
Niels Voigt (@niels_voigt) 's Twitter Profile Photo

Thrilled to share our new publication in EHJ Editor-in-Chief! We developed a score that predicts #AFib after cardiac surgery - powered by experimental data from individual patient samples. A proud step bridging bench & bedside. Huge thanks to Stefan Kallenberger & Faks and the whole team

Thrilled to share our new publication in <a href="/ehj_ed/">EHJ Editor-in-Chief</a>!

We developed a score that predicts #AFib after cardiac surgery - powered by experimental data from individual patient samples. A proud step bridging bench &amp; bedside.

Huge thanks to <a href="/doktor_ska/">Stefan Kallenberger</a> &amp; <a href="/funshofaks/">Faks</a> and the whole team
Matthias Nahrendorf (@matthiasnahrend) 's Twitter Profile Photo

Cardiomyocyte-macrophage coupling confirmed in human cells 😍 👇 Human heart-macrophage assembloids mimic immune-cardiac interactions a... sciencedirect.com/science/articl…

Oscar Moreno Loaiza (@oscarmoreno511) 's Twitter Profile Photo

Congrats to Aitor Aguirre and team on this great paper! Exciting to see our findings in mice — IL-1β acting on resident mac to promote AF — now demonstrated in human cells. Impressive work and an important advance for the field! cell.com/cell-stem-cell…